IXHL News and Press, Incannex Healthcare Limited From 12/04/23

2023-12-04 09:30:53 ET Siyata Mobile’s (NASDAQ: SYTA) recent moves are designed to strengthen its footing with major carriers, including AT&T (NYSE: T), Verizon (NYSE: VZ), and T-Mobile (NASDAQ: TMUS), but the moves could propel a market response that parallels Incannex Healthcar...

2023-12-01 12:52:15 ET Gainers: Neximmune ( NEXI ) +304% . Green Giant ( GGE ) +97% . XBP Europe Holdings ( XBP ) +89% . ShiftPixy ( PIXY ) +47% . Clearmind Medicine ( CMND ) +33% . Elastic N.V ( ESTC ) +34% . Gen...

2023-12-01 09:59:03 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom For further details see: Redhill Biopha...

2023-12-01 08:25:56 ET Losers: Smart for Life ( SMFL ) -38% announces exercise of warrants for $1.5 Million gross proceeds . Ampio Pharmaceuticals ( AMPE ) -34% . Incannex Healthcare ( IXHL ) -34% . Vivos Therapeutics ( VVOS ) -14% . ...

MELBOURNE, Australia and NEW YORK, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (NASDAQ: IXHL) is pleased to announce that its previously announced transaction to redomicile Incannex Healthcare from Australia to the United States has been implemented as of yesterday, November 28, 20...

MELBOURNE, Australia, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Incannex Healthcare Limited (ASX: IHL) (NASDAQ: IXHL) (the “ Company ” or “ Incannex ”) is pleased to announce that the Federal Court of Australia (“ Court ”) has today made orders approv...

MELBOURNE, Australia, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), (‘Incannex’ or the ‘Company’) a pharmaceutical company developing cannabinoid pharmaceutical medicines and psychedelic therapies for unmet medical needs, is ...

2023-08-24 14:04:31 ET More on Incannex Healthcare Incannex wins FDA OK to trial cannabinoid-based sleep apnea drug Incannex Healthcare to redomicile from Australia to US, list on Nasdaq Incannex rises 9% after Australia approval to begin phase 1 trial of anti-inflam...

MELBOURNE, Australia, Aug. 24, 2023 (GLOBE NEWSWIRE) -- Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), (‘Incannex’ or the ‘Company’) a clinical-stage pharmaceutical company developing unique medicinal cannabinoid pharmaceutical products and psychedelic medicine...

2023-08-22 10:22:39 ET More on Incannex Incannex Healthcare to redomicile from Australia to US, list on Nasdaq Incannex rises 9% after Australia approval to begin phase 1 trial of anti-inflammatory drug Incannex adds over 19% with positive data for sleep apnea candid...